INDIVIOR PHARMACEUTICALS, INC. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↓-8.7% -$115M
$1.20B
Current Assets↓-21.2% -$175M
$652M
Cash & Equivalents↓-38.9% -$124M
$195M
ST Investments↓-100.0% -$1M
$0
Receivables↓-0.4% -$1M
$253M
Inventory↓-8.4% -$14M
$153M
Net PPE↑+44.0% +$44M
$144M
Goodwill↑+0.0% +$0
$2M
Total Liabilities↓-21.3% -$352M
$1.30B
Current Liabilities↓-1.1% -$10M
$914M
Account Payables↓-23.8% -$15M
$48M
Long-Term Debt↓-7.9% -$25M
$290M
Stockholders Equity↑+70.9% +$239M
$-98M
Retained Earnings↑+45.1% +$200M
$-243M
Operating Lease ROU Asset↓-33.3% -$13M
$26M
Operating Lease Liability↑+0.0% +$0
$32M
Gross PP&E↑+32.1% +$61M
$251M
Accumulated Depreciation↑+18.9% +$17M
$107M
Inventory WIP↓-3.9% -$2M
$49M
Inventory Finished Goods↓-20.2% -$19M
$75M
Debt Due Y1↑+11.3% +$6M
$59M
Debt Due Y2↑+7.8% +$4M
$55M
Debt Due Y3↓-8.8% -$5M
$52M
Debt Due Y4↓-9.1% -$5M
$50M
Debt Due Y5↑+367.3% +$191M
$243M
Debt Due >Y5↓-100.0% -$256M
$0